Hormonal
Performing bariatric surgery during the pre-diabetic or early diabetic stages significantly reduces the incidence of type 2 diabetes and promotes remission, whereas delaying surgery until advanced stages with established complications yields minimal metabolic benefit and higher mortality risk.
If you have obesity and type 2 diabetes (or pre-diabetes), do not wait until your condition is severe or you have complications like kidney or eye damage. Seek bariatric surgery evaluation early. The evidence shows that operating while your diabetes is new or in the pre-diabetic stage offers the highest chance of reversing the disease and preventing long-term damage, whereas waiting until the disease is advanced often fails to provide survival or health benefits.
Available evidences strongly advocate in favor of the application of bariatric surgery in the early phase of this course, possibly in the pre-diabetic or in very early diabetic stages. To reserve surgery to more advanced and complicated stages of the disease seems to confer less benefits for the clinical course of diabetes and exposes these more frail patients to the possible side effects of a rapid weight loss.
Why this rating
Based on multiple RCTs (Dixon, Schauer, Mingrone, Ikramuddin) and large prospective cohorts (SOS), though the paper is a review.
Source
Timing of bariatric surgery in people with obesity and diabetes.
Luca Busetto · PubMed · 2015
DOI 10.3978/j.issn.2305-5839.2015.03.62
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →